Showing results (1241-1250 of 1,308) with videos related to
Sort By:
Pageof 131
Science Translational Medicine|November 22, 2019
Antigenic competition in CD4+ T cell responses in a randomized, multicenter, double-blind clinical HIV vaccine trialEsper G Kallas, Nicole A Grunenberg, Chenchen Yu, et al.Journal of Virology|March 30, 2005
The majority of currently circulating human immunodeficiency virus type 1 clade B viruses fail to prime cytotoxic T-lymphocyte responses against an otherwise immunodominant HLA-A2-restricted epitope: implications for vaccine designMarcus Altfeld, Todd M Allen, Elizabeth T Kalife, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 6, 2007
Increased sequence diversity coverage improves detection of HIV-specific T cell responsesNicole Frahm, Daniel E Kaufmann, Karina Yusim, et al.BMC Cancer|December 29, 2017
Invasive micropapillary carcinoma of the breast overexpresses MUC4 and is associated with poor outcome to adjuvant trastuzumab in HER2-positive breast cancerMaría F Mercogliano, Gloria Inurrigarro, Mara De Martino, et al.Plos One|August 20, 2009
HLA-associated immune escape pathways in HIV-1 subtype B Gag, Pol and Nef proteinsZabrina L Brumme, Mina John, Jonathan M Carlson, et al.Plos One|May 10, 2016
Comparative Immunogenicity of HIV-1 gp140 Vaccine Delivered by Parenteral, and Mucosal Routes in Female Volunteers; MUCOVAC2, A Randomized Two Centre StudyCatherine A Cosgrove, Charles J Lacey, Alethea V Cope, et al.Neuro-Oncology Advances|October 14, 2021
Anesthesia triggers drug delivery to experimental glioma in mice by hijacking caveolar transportLena Spieth, Stefan A Berghoff, Sina K Stumpf, et al.Nature Microbiology|March 27, 2025
Metabolic modelling reveals the aging-associated decline of host-microbiome metabolic interactions in miceLena Best, Thomas Dost, Daniela Esser, et al.Vaccine|October 27, 2016
A study of vaccine-induced immune pressure on breakthrough infections in the Phambili phase 2b HIV-1 vaccine efficacy trialT Hertz, M G Logan, M Rolland, et al.Ebiomedicine|February 2, 2024
Polytopic fractional delivery of an HIV vaccine alters cellular responses and results in increased epitope breadth in a phase 1 randomized trialMaurine D Miner, Allan deCamp, Nicole Grunenberg, et al.Pageof 131